253 related articles for article (PubMed ID: 31152916)
1. Alternative splicing in lung cancer.
Coomer AO; Black F; Greystoke A; Munkley J; Elliott DJ
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194388. PubMed ID: 31152916
[TBL] [Abstract][Full Text] [Related]
2. The regulation properties of RNA secondary structure in alternative splicing.
Bartys N; Kierzek R; Lisowiec-Wachnicka J
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194401. PubMed ID: 31323437
[TBL] [Abstract][Full Text] [Related]
3. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation.
Bechara EG; Sebestyén E; Bernardis I; Eyras E; Valcárcel J
Mol Cell; 2013 Dec; 52(5):720-33. PubMed ID: 24332178
[TBL] [Abstract][Full Text] [Related]
4. Small non-coding RNA within the endogenous spliceosome and alternative splicing regulation.
Sperling R
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194406. PubMed ID: 31323432
[TBL] [Abstract][Full Text] [Related]
5. The role of alternative splicing in lung cancer.
Ning X; Fu Z; Zhang J; Gao S; Cui Z; Cong M; Guo Q; Sun X; Li J; Zhang M; Wang S
Cancer Chemother Pharmacol; 2023 Aug; 92(2):83-95. PubMed ID: 37335335
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial regulation of alternative splicing.
Shenasa H; Hertel KJ
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194392. PubMed ID: 31276857
[TBL] [Abstract][Full Text] [Related]
7. Repeat-associated RNA structure and aberrant splicing.
Hale MA; Johnson NE; Berglund JA
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194405. PubMed ID: 31323433
[TBL] [Abstract][Full Text] [Related]
8. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
Zhang S; Bao Y; Shen X; Pan Y; Sun Y; Xiao M; Chen K; Wei H; Zuo J; Saffen D; Zong WX; Sun Y; Wang Z; Wang Y
EBioMedicine; 2020 Nov; 61():103067. PubMed ID: 33130397
[TBL] [Abstract][Full Text] [Related]
9. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
10. More than a messenger: Alternative splicing as a therapeutic target.
Black AJ; Gamarra JR; Giudice J
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194395. PubMed ID: 31271898
[TBL] [Abstract][Full Text] [Related]
11. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing.
Zong FY; Fu X; Wei WJ; Luo YG; Heiner M; Cao LJ; Fang Z; Fang R; Lu D; Ji H; Hui J
PLoS Genet; 2014 Apr; 10(4):e1004289. PubMed ID: 24722255
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression.
Feng H; Jin Z; Liu K; Peng Y; Jiang S; Wang C; Hu J; Shen X; Qiu W; Cheng X; Zhao R
J Cell Mol Med; 2020 Nov; 24(21):12667-12680. PubMed ID: 32939931
[TBL] [Abstract][Full Text] [Related]
13. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
[TBL] [Abstract][Full Text] [Related]
14. Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.
Tessier SJ; Loiselle JJ; McBain A; Pullen C; Koenderink BW; Roy JG; Sutherland LC
BMC Res Notes; 2015 Feb; 8():46. PubMed ID: 25889998
[TBL] [Abstract][Full Text] [Related]
15. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
de Miguel FJ; Pajares MJ; Martínez-Terroba E; Ajona D; Morales X; Sharma RD; Pardo FJ; Rouzaut A; Rubio A; Montuenga LM; Pio R
Mol Oncol; 2016 Nov; 10(9):1437-1449. PubMed ID: 27555542
[TBL] [Abstract][Full Text] [Related]
16. Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells.
Blijlevens M; Komor MA; Sciarrillo R; Smit EF; Fijneman RJA; van Beusechem VW
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545483
[TBL] [Abstract][Full Text] [Related]
17. QKI-5 regulates the alternative splicing of cytoskeletal gene ADD3 in lung cancer.
Wang JZ; Fu X; Fang Z; Liu H; Zong FY; Zhu H; Yu YF; Zhang XY; Wang SF; Huang Y; Hui J
J Mol Cell Biol; 2021 Aug; 13(5):347-360. PubMed ID: 33196842
[TBL] [Abstract][Full Text] [Related]
18. Context matters: Regulation of splice donor usage.
Ptok J; Müller L; Theiss S; Schaal H
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194391. PubMed ID: 31202784
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of splicing in cancer.
Lee SC; Abdel-Wahab O
Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.
Zhao J; Sun Y; Huang Y; Song F; Huang Z; Bao Y; Zuo J; Saffen D; Shao Z; Liu W; Wang Y
Sci Rep; 2017 Jan; 7():40488. PubMed ID: 28091594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
